{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:05:50Z","timestamp":1784322350925,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apjo.2026.100348","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:13:43Z","timestamp":1783919623000},"page":"100348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A classification model for predicting corticosteroid and cyclosporin A responsiveness in pediatric idiopathic uveitis"],"prefix":"10.1016","author":[{"given":"Rui","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-6619","authenticated-orcid":false,"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjo.2026.100348_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/acr.24056","article-title":"Clinical presentation, management, and long-term outcome of Pars Planitis, Panuveitis, and Vogt-Koyanagi-Harada disease in children and adolescents","volume":"72","author":"Reiff","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.apjo.2026.100348_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17469899.2019.1663731","article-title":"Update on the management of uveitis in children: an overview for the clinician","volume":"14","author":"Kim","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100348_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/09273948.2017.1420202","article-title":"The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States","volume":"27","author":"Ferrara","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.apjo.2026.100348_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/ocii.8.4.251.6459","article-title":"Uveitis in children","volume":"8","author":"Cunningham","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.apjo.2026.100348_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/09273948.2018.1502325","article-title":"Pattern of Childhood Uveitis in Egypt","volume":"27","author":"Abd El Latif","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.apjo.2026.100348_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2026.100348_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/IAE.0000000000002885","article-title":"RETINAL VASCULITIS, A COMMON MANIFESTATION OF IDIOPATHIC PEDIATRIC UVEITIS?","volume":"41","author":"Yang","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2026.100348_bib8","article-title":"MicroRNA-146a and Ets-1 gene polymorphisms are associated with pediatric uveitis","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2026.100348_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12886-023-03117-7","article-title":"Comprehensive evaluation of functional vision, quality of life, and cognitive ability in pediatric uveitis","volume":"23","author":"Wan","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100348_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41390-019-0612-4","article-title":"Association of apoptosis genes in PDCD1 but not PDCD1LG2, FAS, and FASLG with pediatric idiopathic uveitis in Han Chinese","volume":"87","author":"Pang","year":"2020","journal-title":"Pediatr Res"},{"key":"10.1016\/j.apjo.2026.100348_bib11","article-title":"Recent advances in the treatment of juvenile idiopathic arthritis-associated uveitis","volume":"13","author":"Chen","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100348_bib12","article-title":"Scalability of mass spectrometry-based metabolomics for natural extracts libraries exploration: current status, challenges, and opportunities","author":"Rutz","year":"2025","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apjo.2026.100348_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fonc.2020.00717","article-title":"LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.apjo.2026.100348_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9292","article-title":"Development and validation of a sensitive and reliable targeted metabolomics method for the quantification of cardiovascular disease-related biomarkers in plasma using ultrahigh-performance liquid chromatography-tandem mass spectrometry","volume":"36","author":"Gao","year":"2022","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.apjo.2026.100348_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108070","article-title":"Plasma metabolomics study of Vogt-Koyanagi-Harada disease identifies potential diagnostic biomarkers","volume":"196","author":"Chen","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.apjo.2026.100348_bib16","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202502523RR","article-title":"The Gut-Spleen Axis in Liver Disease: Mechanistic Insights Into Metabolism, Metabolome, and Microbiome Interactions","volume":"39","author":"Dey","year":"2025","journal-title":"Faseb J"},{"key":"10.1016\/j.apjo.2026.100348_bib17","doi-asserted-by":"crossref","first-page":"e2700","DOI":"10.1210\/clinem\/dgae812","article-title":"Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study","volume":"110","author":"Jiang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apjo.2026.100348_bib18","first-page":"785","article-title":"Construction and efficacy of a prediction model for short-term mortality risk in sepsis patients based on magnetic resonance metabolomics features","volume":"47","author":"Zhang","year":"2024","journal-title":"J Mol Imaging"},{"key":"10.1016\/j.apjo.2026.100348_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13113097","article-title":"Diagnosis and Treatment of Uveitis in Children: A Summary of the Latest Data from a 5-Year Literature Review (2018-2023)","volume":"13","author":"Modrzejewska","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.apjo.2026.100348_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109800","article-title":"Identification of FCER1G as a cyclosporin A plus corticosteroid sensitization gene in female patients with Vogt-Koyanagi-Harada disease","volume":"256","author":"Chang","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.apjo.2026.100348_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102465","article-title":"Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene","volume":"112","author":"Chang","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apjo.2026.100348_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/ICU.0b013e3283641ede","article-title":"Pediatric uveitis: new and future treatments","volume":"24","author":"Mehta","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100348_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","article-title":"Role of lysosomes in physiological activities, diseases, and therapy","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apjo.2026.100348_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/17425255.2015.1028356","article-title":"Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism","volume":"11","author":"Joyce","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apjo.2026.100348_bib25","article-title":"Targeting Metabolic-Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxid (Basel)"},{"key":"10.1016\/j.apjo.2026.100348_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.trecan.2021.02.004","article-title":"Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids","volume":"7","author":"Pranzini","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apjo.2026.100348_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.768606","article-title":"Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells","volume":"13","author":"Saito","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apjo.2026.100348_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12974-023-02701-4","article-title":"Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis","volume":"20","author":"Zhu","year":"2023","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.apjo.2026.100348_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acsmedchemlett.1c00679","article-title":"Therapeutic Potential of Monoacylglycerol Lipase (MGL) Inhibitors as Treatment for Pain, Depression, Cancers, and Eye Conditions","volume":"13","author":"Abdel-Magid","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apjo.2026.100348_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apjo.2026.100348_bib31","article-title":"Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer","author":"Feng","year":"2020","journal-title":"Cancer Drug Resist 3 117"},{"key":"10.1016\/j.apjo.2026.100348_bib32","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1038\/s41467-025-62134-w","article-title":"Mogat1 drives metabolic adaptations to evade immune surveillance","volume":"16","author":"Wei","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apjo.2026.100348_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.apjo.2026.100348_bib34","first-page":"253","article-title":"Sphingolipids with inositolphosphate-containing head groups","volume":"26","author":"Lester","year":"1993","journal-title":"Adv Lipid Res"},{"key":"10.1016\/j.apjo.2026.100348_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apjo.2026.100348_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molcel.2010.10.005","article-title":"Membranes in balance: mechanisms of sphingolipid homeostasis","volume":"40","author":"Breslow","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.apjo.2026.100348_bib37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/mmi.14586","article-title":"Sphingolipids: Regulators of azole drug resistance and fungal pathogenicity","volume":"114","author":"Song","year":"2020","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.apjo.2026.100348_bib38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s12885-018-4714-x","article-title":"LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apjo.2026.100348_bib39","article-title":"LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2026.100348_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258363","article-title":"Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells","volume":"16","author":"Shammout","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2026.100348_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.apjo.2026.100348_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103051","article-title":"N-acetyl-aspartate metabolism at the interface of cancer, immunity, and neurodegeneration","volume":"85","author":"Krause","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.apjo.2026.100348_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102585","article-title":"Hindering NAT8L expression in hepatocellular carcinoma increases cytosolic aspartate delivery that fosters pentose phosphate pathway and purine biosynthesis promoting cell proliferation","volume":"59","author":"De Falco","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.apjo.2026.100348_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40170-016-0150-z","article-title":"Bridging the gap between non-targeted stable isotope labeling and metabolic flux analysis","volume":"4","author":"Weindl","year":"2016","journal-title":"Cancer Metab"},{"key":"10.1016\/j.apjo.2026.100348_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjophthalmol-2020-315960","article-title":"Prevalence and clinical features of systemic diseases in Chinese patients with uveitis","volume":"105","author":"Yang","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2026.100348_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.9.5.12","article-title":"Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis","volume":"9","author":"Tagirasa","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.apjo.2026.100348_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119066","article-title":"De novo lipid synthesis in cardiovascular tissue and disease","volume":"400","author":"Khan","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apjo.2026.100348_bib48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jgg.2023.06.006","article-title":"Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity","volume":"51","author":"Mu","year":"2024","journal-title":"J Genet Genom"},{"key":"10.1016\/j.apjo.2026.100348_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fct.2010.10.011","article-title":"Subchronic oral toxicity assessment of N-acetyl-L-aspartic acid in rats","volume":"49","author":"Karaman","year":"2011","journal-title":"Food Chem Toxicol"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098926000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098926000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:38:22Z","timestamp":1784320702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162098926000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S2162098926000745"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2026.100348","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A classification model for predicting corticosteroid and cyclosporin A responsiveness in pediatric idiopathic uveitis","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2026.100348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100348"}}